We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Multicenter, randomized, double-blind, placebo-controlled study of thalidomide plus dexamethasone compared with dexamethasone as initial therapy for newly diagnosed multiple myeloma.
- Authors
Rajkumar, S Vincent; Rosiñol, Laura; Hussein, Mohamad; Catalano, John; Jedrzejczak, Wieslaw; Lucy, Lela; Olesnyckyj, Marta; Yu, Zhinuan; Knight, Robert; Zeldis, Jerome B; Bladé, Joan
- Abstract
The long-term impact of thalidomide plus dexamethasone (thal/dex) as primary therapy for newly diagnosed multiple myeloma (MM) is unknown. The goal of this study was to compare thalidomide plus dexamethasone versus placebo plus dexamethasone (placebo/dex)as primary therapy for newly diagnosed MM.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Vol 26, Issue 13, p2171
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2007.14.1853